Hyundai Pharm’s paroxetine CR debuts in antidepression market

Hyundai Pharm has released an oral controlled release type of antidepressant paroxetine as part of efforts to expand its product line-up.

Paroxetine CR is indicated for treatment of depression, panic disorder, social anxiety disorder, and premenstrual dysphoric disorder. Part of a class of drugs known as SSRI antidepressants, it works by helping to keep the levels of a certain chemical in th...